How long should small lung lesions of ground-glass opacity be followed?

Journal of Thoracic Oncology

Volumn 8, Issue 3, 2013, Pages 309-314

  Kobayashi, Yoshihisa ^a   Fukui, Takayuki ^a,b   Ito, Simon ^a   Usami, Noriyasu ^a   Hatooka, Shunzo ^a,c   Yatabe, Yasushi ^a,d   Mitsudomi, Tetsuya ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Ichinomiya Nishi Hospital   (Japan)

^d KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Follow up; Ground glass opacity; Lung cancer; Small lung lesion

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FOLLOW UP; GROUND GLASS OPACITY; HUMAN; LUNG LESION; LUNG NODULE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIODIAGNOSIS; SOLID TUMOR; TUMOR GROWTH; TUMOR VOLUME;

EID: 84874038731     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e31827e2435     Document Type: Article

References (25)

1. Hansell DM, Bankier AA, MacMahon H, McLoud TC, Müller NL, Remy J. Fleischner Society: glossary of terms for thoracic imaging. Radiology 2008;246: 697-722.
2. Park CM, Goo JM, Lee HJ, Lee CH, Chun EJ, Im JG. Nodular groundglass opacity at thin-section CT: histologic correlation and evaluation of change at follow-up. Radiographics 2007;27: 391-408.
3. Yang ZG, Sone S, Takashima S, et al. High-resolution CT analysis of small peripheral lung adenocarcinomas revealed on screening helical CT. AJR Am J Roentgenol 2001;176: 1399-1407.
4. Kodama K, Higashiyama M, Yokouchi H, et al. Prognostic value of ground-glass opacity found in small lung adenocarcinoma on high-resolution CT scanning. Lung Cancer 2001;33: 17-25.
5. Aoki T, Tomoda Y, Watanabe H, et al. Peripheral lung adenocarcinoma: correlation of thin-section CT findings with histologic prognostic factors and survival. Radiology 2001;220: 803-809.
6. Fukui T, Yatabe Y, Kobayashi Y, et al. Clinicoradiologic characteristics of patients with lung adenocarcinoma harboring EML4-ALK fusion oncogene. Lung Cancer 2012;77: 319-325.
7. Suzuki K, Koike T, Asakawa T, et al.; Japan Lung Cancer Surgical Study Group (JCOG LCSSG). A prospective radiological study of thin-section computed tomography to predict pathological noninvasiveness in peripheral clinical IA lung cancer (Japan Clinical Oncology Group 0201). J Thorac Oncol 2011;6: 751-756.
8. Travis WD, Brambilla E, Noguchi M, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma. J Thorac Oncol 2011;6: 244-285.
9. Hasegawa M, Sone S, Takashima S, et al. Growth rate of small lung cancers detected on mass CT screening. Br J Radiol 2000;73: 1252-1259.
10. Aoki T, Nakata H, Watanabe H, et al. Evolution of peripheral lung adenocarcinomas: CT findings correlated with histology and tumor doubling time. AJR Am J Roentgenol 2000;174: 763-768.
11. Yatabe Y, Borczuk AC, Powell CA. Do all lung adenocarcinomas follow a stepwise progression? Lung Cancer 2011;74: 7-11.
12. Sakamoto H, Shimizu J, Horio Y, et al. Disproportionate representation of KRAS gene mutation in atypical adenomatous hyperplasia, but even distribution of EGFR gene mutation from preinvasive to invasive adenocarcinomas. J Pathol 2007;212: 287-294.
13. Kosaka T, Yatabe Y, Endoh H, Kuwano H, Takahashi T, Mitsudomi T. Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications. Cancer Res 2004;64: 8919-8923.
14. Takigawa N, Segawa Y, Nakata M, et al. Clinical investigation of atypical adenomatous hyperplasia of the lung. Lung Cancer 1999;25: 115-121.
15. Chapman AD, Kerr KM. The association between atypical adenomatous hyperplasia and primary lung cancer. Br J Cancer 2000;83: 632-636.
16. Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365: 395-409.
17. van Iersel CA, de Koning HJ, Draisma G, et al. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 2007;120: 868-874.
18. Jacobson FL, Austin JH, Field JK, et al. Development of The American Association for Thoracic Surgery guidelines for low-dose computed tomography scans to screen for lung cancer in North America: recommendations of The American Association for Thoracic Surgery Task Force for Lung Cancer Screening and Surveillance. J Thorac Cardiovasc Surg 2012;144: 25-32.
19. Asamura H. Management of ground-glass opacity lesions. In HI Pass, DP Carbone, DH Johnson, et al. (Eds.), Principles and Practice of Lung Cancer Fourth Edition: The Official Reference Text of the International Association for the Study of Lung Cancer (IASLC). Philadelphia, PA: Lippincott Williams & Wilkins, 2010. Pp. 467-471.
20. A phase III randomised trial of lobectomy versus limited resection (segmentectomy) for small (2 cm or less) peripheral non-small cell lung cancer (JCOG0802/WJOG4607L) [University hospital medical information network web site] Available at: https://upload.umin.ac.jp/cgi-openbin/ctr/ctr.cgi?function= brows&action=brows&recptno=R000002300&t ype=summary&language=E. Accessed October 23, 2012.
21. Phase II Study of Limited Surgical Resection for Peripheral Early Lung Cancer Defined with Thoracic Thin-section Computed Tomography (JCOG0804/WJOG4507L) [University hospital medical information network web site] Available at: https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr.cgi?function= brows&action=brows&recptno=R000002262&type=su mmary&language=E. Accessed October 23, 2012.
22. Ninomiya H, Hiramatsu M, Inamura K, et al. Correlation between morphology and EGFR mutations in lung adenocarcinomas significance of the micropapillary pattern and the hobnail cell type. Lung Cancer 2009;63: 235-240.
23. Yatabe Y, Mitsudomi T. Epidermal growth factor receptor mutations in lung cancers. Pathol Int 2007;57: 233-244.
24. Johnsson ÅA, Fagman E, Vikgren J, et al. Pulmonary nodule size evaluation with chest tomosynthesis. Radiology 2012;265: 273-282.
25. Oda S, Awai K, Murao K, et al. Computer-aided volumetry of pulmonary nodules exhibiting ground-glass opacity at MDCT. AJR Am J Roentgenol 2010;194: 398-406.